» Articles » PMID: 25738804

Association of Six Genetic Variants with Myocardial Infarction

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2015 Mar 5
PMID 25738804
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Although various genes that confer susceptibility to myocardial infarction (MI) have been identified for Caucasian populations in genome-wide association studies (GWAS), genetic variants related to this condition in Japanese individuals have not been identified definitively. The aim of the present study was to examine an association of MI in Japanese individuals with 29 polymorphisms identified as susceptibility loci for MI or coronary artery disease in Caucasian populations by meta-analyses of GWAS. The study subjects comprised 1,824 subjects with MI and 2,329 controls. Genotypes of the polymorphisms were determined by Luminex bead-based multiplex assay. To compensate for multiple comparisons, we adopted the criterion of a false discovery rate (FDR) of <0.05 for statistical significance for association. Comparisons of allele frequencies by the χ(2) test revealed that rs9369640 of the phosphatase and actin regulator 1 gene (PHACTR1, FDR=0.0007), rs4977574 of the CDKN2B antisense RNA 1 gene (CDKN2B-AS1, FDR=0.0038), rs264 of the lipoprotein lipase gene (LPL, FDR=0.0061), rs599839 of the proline/serine-rich coiled-coil 1 gene (PSRC1, FDR=0.0118), rs9319428 of the fms-related tyrosine kinase 1 gene (FLT1, FDR=0.0118) and rs12413409 of the cyclin and CBS domain divalent metal cation transport mediator 2 gene (CNNM2, FDR=0.0300) were significantly associated with MI. Multivariate logistic regression analysis with adjustment for covariates revealed that rs9369640 (P=0.0005; odds ratio, 0.89), rs4977574 (P=0.0001; odds ratio, 1.50), rs264 (P=0.0405; odds ratio, 0.85), rs599839 (P=0.0003; odds ratio, 0.68), rs9319428 (P=0.0155; odds ratio, 1.20) and rs12413409 (P=0.0076; odds ratio, 0.66) were significantly (P<0.05) associated with MI. PHACTR1, CDKN2B-AS1, LPL, PSRC1, FLT1 and CNNM2 may thus be susceptibility loci for MI in Japanese individuals.

Citing Articles

rs264, rs867186 and rs974819 Gene Polymorphisms in Patients with Unstable Angina.

Malinowski D, Safranow K, Pawlik A J Pers Med. 2024; 14(2).

PMID: 38392646 PMC: 10890678. DOI: 10.3390/jpm14020213.


Genetic variations in IKZF3, LET7-a2, and CDKN2B-AS1: Exploring associations with metabolic syndrome susceptibility and clinical manifestations.

Paniri A, Hosseini M, Fattahi S, Amiribozorgi G, Asouri M, Maadi M J Clin Lab Anal. 2024; 38(1-2):e24999.

PMID: 38193570 PMC: 10829692. DOI: 10.1002/jcla.24999.


Association between Genetic Variants of and Cardiovascular Diseases: A Systematic Review and Meta-Analysis.

Castillo-Avila R, Gonzalez-Castro T, Tovilla-Zarate C, Martinez-Magana J, Lopez-Narvaez M, Juarez-Rojop I J Cardiovasc Dev Dis. 2023; 10(3).

PMID: 36975855 PMC: 10056735. DOI: 10.3390/jcdd10030091.


Modular networks and genomic variation during progression from stable angina pectoris through ischemic cardiomyopathy to chronic heart failure.

Chen L, Yu Y, Liu J, Chen Y, Wang B, Qi Y Mol Med. 2022; 28(1):140.

PMID: 36435742 PMC: 9701405. DOI: 10.1186/s10020-022-00569-3.


Effect of 9p21.3 (lncRNA and CDKN2A/2B) variant on lipid profile.

Wei B, Liu Y, Li H, Peng Y, Luo Z Front Cardiovasc Med. 2022; 9:946289.

PMID: 36158791 PMC: 9489913. DOI: 10.3389/fcvm.2022.946289.